|
LLY
|
Eli Lilly and Company
|
5.69%
|
US
|
NYSE
|
|
AZN
|
Astrazeneca Plc
|
5.56%
|
UK
|
LSE
|
|
GILD
|
Gilead Sciences, Inc.
|
4.58%
|
US
|
NASDAQ
|
|
ISRG
|
Intuitive Surgical, Inc.
|
4.52%
|
US
|
NASDAQ
|
|
BSX
|
Boston Scientific Corporation
|
4.42%
|
US
|
NYSE
|
|
PODD
|
Insulet Corporation
|
3.87%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
3.66%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
3.62%
|
US
|
NASDAQ
|
|
DXCM
|
DexCom, Inc.
|
3.36%
|
US
|
NASDAQ
|
|
CSL
|
CSL Limited
|
3.19%
|
AU
|
ASX
|
|
MTD
|
Mettler-Toledo International, Inc.
|
3.18%
|
US
|
NYSE
|
|
EW
|
Edwards Lifesciences Corporation
|
2.91%
|
US
|
NYSE
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
2.72%
|
US
|
NASDAQ
|
|
VEEV
|
Veeva Systems Inc.
|
2.65%
|
US
|
NYSE
|
|
COO
|
Cooper Companies, Inc. (The)
|
2.64%
|
US
|
NYSE
|
|
BIIB
|
Biogen Idec Inc.
|
2.63%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
2.63%
|
US
|
NYSE
|
|
ZBH
|
Zimmer Biomet Holdings, Inc.
|
2.51%
|
US
|
NYSE
|
|
SGEN
|
Seattle Genetics, Inc.
|
2.35%
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
2.21%
|
US
|
NASDAQ
|